Skip to main content
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Krzysztof Tupikowski
Sign up to set email alerts
98
Publications
1,528
Citation Statements Received
1,862
Citation Statements Given
How they've been cited
2,312
41
1,478
9
How they cite others
2,127
129
1,714
19
Affiliations
Wroclaw Medical University
,
Lublin Oncology Center
Publications
Order By: Most citations
Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma
Bajorin
1
,
Witjes
2
,
Gschwend
3
et al.
2021
N Engl J Med
1,155
13
804
1
5
Get access via publisher
Add to collection
Cite
Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer
Chi
1
,
Rathkopf
2
,
Smith
3
et al.
2023
JCO
Abstract
Show
371
5
183
0
Get access via publisher
Add to collection
Cite
Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial
Palou Redorta
1
,
Nishiyama
2
,
Katō
3
et al.
2025
The Lancet
87
2
60
0
Get access via publisher
Add to collection
Cite
Serum lipid peroxides and total antioxidant status in postmenopausal women on hormone replacement therapy
Bednarek-Tupikowska
1
,
Tupikowski
2
,
Bidzińska
3
et al.
2004
Gynecological Endocrinology
63
2
41
2
Get access via publisher
Add to collection
Cite
FIERCE-22: Clinical activity of vofatamab (V) a FGFR3 selective inhibitor in combination with pembrolizumab (P) in WT metastatic urothelial carcinoma, preliminary analysis.
Siefker-Radtke
1
,
Currie
2
,
Abella
3
et al.
2019
JCO
Abstract
Show
65
0
43
0
Get access via publisher
Add to collection
Cite
Association of 3′ nearby gene BTLA polymorphisms with the risk of renal cell carcinoma in the Polish population
Partyka
1
,
Tupikowski
2
,
Kołodziej
3
et al.
2016
Urologic Oncology: Seminars and Original Investigations
Abstract
Show
26
2
39
0
Get access via publisher
Add to collection
Cite
Patient comfort during flexible and rigid cystourethroscopy.
Krajewski
1
,
Zdrojowy
2
,
Wojciechowska
3
et al.
2016
Abstract
Show
27
2
29
0
Get access via publisher
Add to collection
Cite
Effects of oestradiol and oestroprogestin on erythrocyte antioxidative enzyme system activity in postmenopausal women
Bednarek-Tupikowska
1
,
Tworowska
2
,
Jedrychowska
3
et al.
2006
Clinical Endocrinology
Abstract
Show
52
5
29
3
Get access via publisher
Add to collection
Cite
1
2
3
4
5